Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.

Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, Bernik S, Scarpinato V, Mills C.

Ann Surg Oncol. 2004 Aug;11(8):739-46. Epub 2004 Jul 12.

PMID:
15249336
2.

Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.

Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R.

Am J Surg. 2006 Oct;192(4):427-33.

PMID:
16978943
3.

Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.

Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A, White J, Hedberg P, Hebert M, Arthur D, Zannis V, Quiet C, Streeter O, Silverstein M.

Am J Surg. 2007 Oct;194(4):456-62.

PMID:
17826055
4.

Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.

Harper JL, Jenrette JM, Vanek KN, Aguero EG, Gillanders WE.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):169-74.

PMID:
15629608
5.

Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.

Niehoff P, Polgár C, Ostertag H, Major T, Sulyok Z, Kimmig B, Kovács G.

Radiother Oncol. 2006 Jun;79(3):316-20. Epub 2006 Jun 14.

PMID:
16780977
6.

Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.

Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D.

Am J Clin Oncol. 2009 Jun;32(3):314-8. doi: 10.1097/COC.0b013e31818af0b9.

PMID:
19451803
7.
8.

Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator.

Dickler A, Kirk MC, Choo J, Hsi WC, Chu J, Dowlatshahi K, Francescatti D, Shott S, Nguyen C.

Breast J. 2005 Sep-Oct;11(5):306-10.

PMID:
16174149
9.

Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study.

Belkacémi Y, Chauvet MP, Giard S, Villette S, Lacornerie T, Bonodeau F, Baranzelli MC, Bonneterre J, Lartigau E.

Radiother Oncol. 2009 Jan;90(1):23-9. doi: 10.1016/j.radonc.2008.06.004. Epub 2008 Aug 8.

PMID:
18692927
10.

Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.

Wallace M, Martinez A, Mitchell C, Chen PY, Ghilezan M, Benitez P, Brown E, Vicini F.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):531-6. doi: 10.1016/j.ijrobp.2009.05.043. Epub 2009 Sep 21.

PMID:
19775830
11.

Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.

Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, Gilbert S, Kunzman J, Benitez P, Martinez A.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):32-40. Epub 2007 Apr 30.

PMID:
17467920
12.

First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.

Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Kuerer H, Whitacre EB, Whitworth PW, Fine RE, Haffty BG, Arrambide LS.

Cancer. 2005 Sep 15;104(6):1138-48.

13.

TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.

Perera F, Chisela F, Stitt L, Engel J, Venkatesan V.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1283-90.

PMID:
16029783
14.

Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.

Póti Z, Nemeskéri C, Fekésházy A, Sáfrány G, Bajzik G, Nagy ZP, Bidlek M, Sinkovics I, Udvarhelyi N, Liszkay G, Repa I, Galuska L, Trón L, Mayer A, Esik O.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1022-33.

PMID:
15001241
15.
16.

Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).

Vicini F, Beitsch PD, Quiet CA, Keleher AJ, Garcia D, Snider HC Jr, Gittleman MA, Zannis VJ, Kuerer HM, Lyden M.

Cancer. 2008 Feb 15;112(4):758-66. doi: 10.1002/cncr.23227.

17.

Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.

Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):489-95. Epub 2005 Oct 24.

PMID:
16246495
18.

Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.

Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, Gustafson G, Martinez A.

Am J Surg. 2004 Oct;188(4):355-64.

PMID:
15474426
19.

Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.

Kuske RR, Winter K, Arthur DW, Bolton J, Rabinovitch R, White J, Hanson W, Wilenzick RM.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):45-51. Epub 2006 Feb 28.

PMID:
16503383
20.

Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.

Kaufman SA, DiPetrillo TA, Price LL, Midle JB, Wazer DE.

Brachytherapy. 2007 Oct-Dec;6(4):286-92.

PMID:
17991625

Supplemental Content

Support Center